Amerika Serikat -
Inggris -
NLM (National Library of Medicine)
melatonin phenolic- melatonin liquid
energique, inc. - melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl) - may temporarily relieve symptoms associated with reactions to melatonin such as sleeplessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve symptoms associated with reactions to melatonin such as sleeplessness.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
blooms the chemist melatonin mr melatonin 2 mg modified release tablet blister pack
apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
terry white chemists melatonin mr melatonin 2 mg modified release tablet blister pack
apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
chemmart melatonin mr melatonin 2 mg modified release tablet blister pack
apotex pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: ammonio methacrylate copolymer; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; purified talc; magnesium stearate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
apohealth melatonin sleep aid melatonin 2 mg modified release tablet blister pack
generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: magnesium stearate; ammonio methacrylate copolymer; colloidal anhydrous silica; lactose monohydrate; calcium hydrogen phosphate dihydrate; purified talc - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
chemists' own melatonin sleep aid melatonin 2 mg modified release tablet blister pack
generic partners pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate dihydrate; purified talc; colloidal anhydrous silica; ammonio methacrylate copolymer; magnesium stearate; lactose monohydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
melatonin mr-tv melatonin 2 mg modified release tablet blister pack
teva pharma australia pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; ammonio methacrylate copolymer; lactose monohydrate; magnesium stearate; purified talc; calcium hydrogen phosphate dihydrate - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Australia -
Inggris -
Department of Health (Therapeutic Goods Administration)
melatonin sandoz sleep aid melatonin 2 mg modified release tablet blister pack
sandoz pty ltd - melatonin, quantity: 2 mg - tablet, modified release - excipient ingredients: calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; ammonio methacrylate copolymer; magnesium stearate; lactose monohydrate; purified talc - monotherapy for the short term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
Malta -
Inggris -
Medicines Authority
senaxa pr, 2 mg prolonged-release tablets
przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics
Malta -
Inggris -
Medicines Authority
meldream pr, 2 mg prolonged-release tablets
przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - prolonged-release tablet - melatonin 2 mg - psycholeptics